Whitehawk Therapeutics (WHWK) Payables (2010 - 2026)

Whitehawk Therapeutics (WHWK) has 17 years of Payables data on file, last reported at $1.7 million in Q1 2026.

• On a quarterly basis, Payables fell 52.28% year-over-year to $1.7 million in Q1 2026; TTM through Mar 2026 was $1.7 million, a 52.28% decrease from a year earlier, with the FY2025 full-year figure at $917000.0, down 57.53% from the prior year.
• Payables for Q1 2026 stood at $1.7 million, up from $917000.0 in the prior quarter.
• Over the last five years, Payables for WHWK reached as high as $6.5 million in Q1 2023 and fell as low as $917000.0 in Q4 2025.
• Historically, Payables has averaged $3.1 million across 5 years, with a median of $3.1 million in 2024.
• Across the five-year window, Payables soared 774.29% in 2022 and sank 63.39% in 2024, its largest moves.
• Year by year, Payables stood at $3.5 million in 2022, then jumped by 67.6% to $5.9 million in 2023, then sank by 63.39% to $2.2 million in 2024, then sank by 57.53% to $917000.0 in 2025, then surged by 90.29% to $1.7 million in 2026.
• Per Business Quant data, the three most recent Payables figures were $1.7 million in Q1 2026, $917000.0 in Q4 2025, and $1.6 million in Q3 2025.